MODULATORS OF THE ADENOSINE A2A RECEPTOR

The present invention relates to the compounds of formula (I) and salts, stereoisomers, tautomers, isotopologues, or N-oxides thereof. The present invention is further concerned with the use of such a compounds or salt, stereoisomer, tautomer, isotopologues, or N- oxide thereof as modulators of the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RAJDA, Anna, WYREBEK, Przemyslaw, FABRITIUS, Charles-Henry, PORTER, Roderick Alan, ZASTAWNA, Magdalena, SZEREMETA-SPISAK, Joanna, GALEZOWSKI, Michal, NOWOGRODZKI, Marcin, WRONOWSKI, Marek, LOZINSKA-RAJ, Iwona, BOBOWSKA, Aneta, DUDEK, Marcelina, SWIRSKI, Mateusz, JANIGA, Anita, STASI, Luigi, REUS, Jacek, OBARA, Alicja
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	RAJDA, Anna WYREBEK, Przemyslaw FABRITIUS, Charles-Henry PORTER, Roderick Alan ZASTAWNA, Magdalena SZEREMETA-SPISAK, Joanna GALEZOWSKI, Michal NOWOGRODZKI, Marcin WRONOWSKI, Marek LOZINSKA-RAJ, Iwona BOBOWSKA, Aneta DUDEK, Marcelina SWIRSKI, Mateusz JANIGA, Anita STASI, Luigi REUS, Jacek OBARA, Alicja
description	The present invention relates to the compounds of formula (I) and salts, stereoisomers, tautomers, isotopologues, or N-oxides thereof. The present invention is further concerned with the use of such a compounds or salt, stereoisomer, tautomer, isotopologues, or N- oxide thereof as modulators of the adenosine A2A receptor in the treatment of cancer and a pharmaceutical composition comprising said compounds. La présente invention concerne les composés de formule (I) et des sels, stéréoisomères, tautomères, isotopologues ou N-oxydes de ceux-ci. La présente invention concerne en outre l'utilisation de tels composés ou sels, stéréo-isomères, tautomères, isotopologues ou N-oxydes de ceux-ci en tant que modulateurs du récepteur A2A de l'adénosine dans le traitement du cancer et une composition pharmaceutique comprenant lesdits composés.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2020128036A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2020128036A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2020128036A13</originalsourceid><addsrcrecordid>eNrjZNDw9XcJ9XEM8Q8KVvB3UwjxcFVwdHH18w_29AOyjBwVglydXQOA0jwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JD7c38jAyMDQyMLA2MzR0Jg4VQCBsCS9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MODULATORS OF THE ADENOSINE A2A RECEPTOR</title><source>esp@cenet</source><creator>RAJDA, Anna ; WYREBEK, Przemyslaw ; FABRITIUS, Charles-Henry ; PORTER, Roderick Alan ; ZASTAWNA, Magdalena ; SZEREMETA-SPISAK, Joanna ; GALEZOWSKI, Michal ; NOWOGRODZKI, Marcin ; WRONOWSKI, Marek ; LOZINSKA-RAJ, Iwona ; BOBOWSKA, Aneta ; DUDEK, Marcelina ; SWIRSKI, Mateusz ; JANIGA, Anita ; STASI, Luigi ; REUS, Jacek ; OBARA, Alicja</creator><creatorcontrib>RAJDA, Anna ; WYREBEK, Przemyslaw ; FABRITIUS, Charles-Henry ; PORTER, Roderick Alan ; ZASTAWNA, Magdalena ; SZEREMETA-SPISAK, Joanna ; GALEZOWSKI, Michal ; NOWOGRODZKI, Marcin ; WRONOWSKI, Marek ; LOZINSKA-RAJ, Iwona ; BOBOWSKA, Aneta ; DUDEK, Marcelina ; SWIRSKI, Mateusz ; JANIGA, Anita ; STASI, Luigi ; REUS, Jacek ; OBARA, Alicja</creatorcontrib><description>The present invention relates to the compounds of formula (I) and salts, stereoisomers, tautomers, isotopologues, or N-oxides thereof. The present invention is further concerned with the use of such a compounds or salt, stereoisomer, tautomer, isotopologues, or N- oxide thereof as modulators of the adenosine A2A receptor in the treatment of cancer and a pharmaceutical composition comprising said compounds. La présente invention concerne les composés de formule (I) et des sels, stéréoisomères, tautomères, isotopologues ou N-oxydes de ceux-ci. La présente invention concerne en outre l'utilisation de tels composés ou sels, stéréo-isomères, tautomères, isotopologues ou N-oxydes de ceux-ci en tant que modulateurs du récepteur A2A de l'adénosine dans le traitement du cancer et une composition pharmaceutique comprenant lesdits composés.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200625&DB=EPODOC&CC=WO&NR=2020128036A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200625&DB=EPODOC&CC=WO&NR=2020128036A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RAJDA, Anna</creatorcontrib><creatorcontrib>WYREBEK, Przemyslaw</creatorcontrib><creatorcontrib>FABRITIUS, Charles-Henry</creatorcontrib><creatorcontrib>PORTER, Roderick Alan</creatorcontrib><creatorcontrib>ZASTAWNA, Magdalena</creatorcontrib><creatorcontrib>SZEREMETA-SPISAK, Joanna</creatorcontrib><creatorcontrib>GALEZOWSKI, Michal</creatorcontrib><creatorcontrib>NOWOGRODZKI, Marcin</creatorcontrib><creatorcontrib>WRONOWSKI, Marek</creatorcontrib><creatorcontrib>LOZINSKA-RAJ, Iwona</creatorcontrib><creatorcontrib>BOBOWSKA, Aneta</creatorcontrib><creatorcontrib>DUDEK, Marcelina</creatorcontrib><creatorcontrib>SWIRSKI, Mateusz</creatorcontrib><creatorcontrib>JANIGA, Anita</creatorcontrib><creatorcontrib>STASI, Luigi</creatorcontrib><creatorcontrib>REUS, Jacek</creatorcontrib><creatorcontrib>OBARA, Alicja</creatorcontrib><title>MODULATORS OF THE ADENOSINE A2A RECEPTOR</title><description>The present invention relates to the compounds of formula (I) and salts, stereoisomers, tautomers, isotopologues, or N-oxides thereof. The present invention is further concerned with the use of such a compounds or salt, stereoisomer, tautomer, isotopologues, or N- oxide thereof as modulators of the adenosine A2A receptor in the treatment of cancer and a pharmaceutical composition comprising said compounds. La présente invention concerne les composés de formule (I) et des sels, stéréoisomères, tautomères, isotopologues ou N-oxydes de ceux-ci. La présente invention concerne en outre l'utilisation de tels composés ou sels, stéréo-isomères, tautomères, isotopologues ou N-oxydes de ceux-ci en tant que modulateurs du récepteur A2A de l'adénosine dans le traitement du cancer et une composition pharmaceutique comprenant lesdits composés.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDw9XcJ9XEM8Q8KVvB3UwjxcFVwdHH18w_29AOyjBwVglydXQOA0jwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JD7c38jAyMDQyMLA2MzR0Jg4VQCBsCS9</recordid><startdate>20200625</startdate><enddate>20200625</enddate><creator>RAJDA, Anna</creator><creator>WYREBEK, Przemyslaw</creator><creator>FABRITIUS, Charles-Henry</creator><creator>PORTER, Roderick Alan</creator><creator>ZASTAWNA, Magdalena</creator><creator>SZEREMETA-SPISAK, Joanna</creator><creator>GALEZOWSKI, Michal</creator><creator>NOWOGRODZKI, Marcin</creator><creator>WRONOWSKI, Marek</creator><creator>LOZINSKA-RAJ, Iwona</creator><creator>BOBOWSKA, Aneta</creator><creator>DUDEK, Marcelina</creator><creator>SWIRSKI, Mateusz</creator><creator>JANIGA, Anita</creator><creator>STASI, Luigi</creator><creator>REUS, Jacek</creator><creator>OBARA, Alicja</creator><scope>EVB</scope></search><sort><creationdate>20200625</creationdate><title>MODULATORS OF THE ADENOSINE A2A RECEPTOR</title><author>RAJDA, Anna ; WYREBEK, Przemyslaw ; FABRITIUS, Charles-Henry ; PORTER, Roderick Alan ; ZASTAWNA, Magdalena ; SZEREMETA-SPISAK, Joanna ; GALEZOWSKI, Michal ; NOWOGRODZKI, Marcin ; WRONOWSKI, Marek ; LOZINSKA-RAJ, Iwona ; BOBOWSKA, Aneta ; DUDEK, Marcelina ; SWIRSKI, Mateusz ; JANIGA, Anita ; STASI, Luigi ; REUS, Jacek ; OBARA, Alicja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2020128036A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RAJDA, Anna</creatorcontrib><creatorcontrib>WYREBEK, Przemyslaw</creatorcontrib><creatorcontrib>FABRITIUS, Charles-Henry</creatorcontrib><creatorcontrib>PORTER, Roderick Alan</creatorcontrib><creatorcontrib>ZASTAWNA, Magdalena</creatorcontrib><creatorcontrib>SZEREMETA-SPISAK, Joanna</creatorcontrib><creatorcontrib>GALEZOWSKI, Michal</creatorcontrib><creatorcontrib>NOWOGRODZKI, Marcin</creatorcontrib><creatorcontrib>WRONOWSKI, Marek</creatorcontrib><creatorcontrib>LOZINSKA-RAJ, Iwona</creatorcontrib><creatorcontrib>BOBOWSKA, Aneta</creatorcontrib><creatorcontrib>DUDEK, Marcelina</creatorcontrib><creatorcontrib>SWIRSKI, Mateusz</creatorcontrib><creatorcontrib>JANIGA, Anita</creatorcontrib><creatorcontrib>STASI, Luigi</creatorcontrib><creatorcontrib>REUS, Jacek</creatorcontrib><creatorcontrib>OBARA, Alicja</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RAJDA, Anna</au><au>WYREBEK, Przemyslaw</au><au>FABRITIUS, Charles-Henry</au><au>PORTER, Roderick Alan</au><au>ZASTAWNA, Magdalena</au><au>SZEREMETA-SPISAK, Joanna</au><au>GALEZOWSKI, Michal</au><au>NOWOGRODZKI, Marcin</au><au>WRONOWSKI, Marek</au><au>LOZINSKA-RAJ, Iwona</au><au>BOBOWSKA, Aneta</au><au>DUDEK, Marcelina</au><au>SWIRSKI, Mateusz</au><au>JANIGA, Anita</au><au>STASI, Luigi</au><au>REUS, Jacek</au><au>OBARA, Alicja</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MODULATORS OF THE ADENOSINE A2A RECEPTOR</title><date>2020-06-25</date><risdate>2020</risdate><abstract>The present invention relates to the compounds of formula (I) and salts, stereoisomers, tautomers, isotopologues, or N-oxides thereof. The present invention is further concerned with the use of such a compounds or salt, stereoisomer, tautomer, isotopologues, or N- oxide thereof as modulators of the adenosine A2A receptor in the treatment of cancer and a pharmaceutical composition comprising said compounds. La présente invention concerne les composés de formule (I) et des sels, stéréoisomères, tautomères, isotopologues ou N-oxydes de ceux-ci. La présente invention concerne en outre l'utilisation de tels composés ou sels, stéréo-isomères, tautomères, isotopologues ou N-oxydes de ceux-ci en tant que modulateurs du récepteur A2A de l'adénosine dans le traitement du cancer et une composition pharmaceutique comprenant lesdits composés.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_WO2020128036A1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	MODULATORS OF THE ADENOSINE A2A RECEPTOR
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T11%3A32%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RAJDA,%20Anna&rft.date=2020-06-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2020128036A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true